2018 Shanghai International Rubber and Plastic Exhibition

上海橡膠展.png

    2018 Shanghai International Rubber and Plastic Exhibition    

   Our company will participate in "CHINAPLAS" in April 24th, 2018 in Shanghai, China. Hongqiao. The National Convention and Exhibition Center was grandly held. More than 3,400 Chinese and foreign exhibitors displayed the latest rubber and plastic raw materials, machinery and technology.



   The first “CHINAPLAS 2016” in Asia and the second in the world will be held from April 25th to 28th this year at the Shanghai New International Expo Center in China. The exhibition area will exceed 240,000 square meters, and more than 3,200 global companies from 13 countries and regions will gather on site.

   Medical plastics will be the highlight of this year's exhibition. There are more than 700 medical related exhibitors. The exhibits cover medical rubber and plastic materials, molds, injection molding and packaging processes, automated production equipment, clean room solutions and detection technologies, including 3D. Print technology, high-precision injection molding, micro-injection molding, new silicone technology for wound care and skin adhesion, or breathable films in medical devices such as artificial heart-lung machines, automated high-speed dispensing and coating systems, and automated balloon molding New materials and processing technologies such as vacuum packaging machines, sterile barrier systems, and clean room solutions have also injected new blood into the medical industry and promoted the rapid development of the medical industry.

   On October 3, 2015, the “Made in China 2025 Key Technology Roadmap” listed biopharmaceuticals and high-performance medical devices as two directions of advanced manufacturing in the medical field, and proposed “to improve the level of innovation and industrialization of medical devices. Focus on the development of high-value diagnostic equipment such as imaging equipment, medical robots, and other high-value medical supplies such as degradable blood vessel stents, and wearable and remote medical treatment products. And in 2014, the “Medical Device Supervision and Management Regulations” of the industry's parent law clearly stated that mainland China encourages the research and innovation of medical devices, promotes the promotion and application of new medical device technologies, and promotes the development of the medical device industry. The introduction of this series of policies has not only raised industry norm requirements for medical terminal enterprises, but also presented greater challenges and opportunities for the upstream supply sector.

   China’s aging population is serious, higher than most developed countries such as the United States. According to official statistics from the mainland, by the end of 2014, the population aged over 60 accounted for 25.6% of the total population. According to the latest United Nations release, by 2050, the number of people over the age of 60 in China will reach 36.5%, plus the implementation of the policy of opening “second child”. As well as the exposure of mainland social medical device incidents, the mainland government has paid more attention to the safety of medical products and has continuously formulated safety product testing standards and policies. This has also forced medical upstream suppliers to continuously develop new alternative materials with excellent safety performance.

   Plastics, as medical materials, need to include the following properties: no toxicity to the body, no carcinogenicity, no allergic reaction or interference with the body's immune mechanism; the material in the implanted body is better in biocompatibility; materials that come in contact with blood should have Certain anticoagulant properties; able to withstand the sterilization process without deformation and so on. The application of plastics in medical treatment has shown a trend of continuous expansion. The innovation of new materials and processing technology has obviously become one of the important factors in the development of the industry. Medical device products require high quality of raw materials and many varieties of demand. Technological advances in the upstream industry will directly affect the technological trend of medical devices. The upstream processing and manufacturing capabilities determine the quality, technical level and cost of raw materials or semi-finished products. To enable medical equipment, consumables, and pharmaceutical packaging suppliers to better grasp the latest applications and practices of medical plastics technology, the 2nd Medical Plastics Forum will be held on April 25-26 for two days. Well-known plastic suppliers, medical rubber and plastics technology experts and leading medical device manufacturers share innovative solutions in the field of medical plastics from all aspects of plastic raw materials, molding processes and clinical applications of products.

   In the field of medical plastic materials technology, the organizer invited the United States Antep Engineering Plastics Co., Ltd. to share the “plastic modification technology that withstands the chemical shock of disinfectants in the hospital” to explain how the newly developed alloy material can withstand the sterilization of most hospitals. The chemical impact of the agent while maintaining the strength, functional and dimensional integrity of the medical device. Tianjin Institute of Plastics Co., Ltd. will share the "PEEK application in the medical field", PEEK has excellent biocompatibility, close to the human bone elastic modulus, X-ray perspective and other unique properties, The medical field has been more and more widely used. For more details, please visit the activity page: chinaplasonline.com/medical2.